4164.0: Tuesday, November 14, 2000: 2:30 PM-4:00 PM | ||||
| ||||
| Purpose: The Collaborative Injection Drug Users Study was conducted in six metropolitan areas of the United States to estimate the prevalence and incidence and identify potential risk factors for human immunodeficiency virus (HIV), hepatitis B and C virus (HBV, HCV), gonorrhea, and chlamydia infections among young, and recently initiated injection drug users (IDUs). This session will provide an overview of the study methods and combined results, as well as site-specific findings. Relevance: The prevalence and incidence of bloodborne viral infections has been shown to be alarmingly high among injection drug users, and during the period shortly after initiation of injection, IDUs appeared to be at greatest risk of infection. High rates of unprotected sex and having multiple sex partners have also been observed in this population placing them at increased risk for other sexually transmitted infections. Importance: Prevalence and incidence rates for these infections provide estimates that can be used to guide healthcare policy and target prevention programs. In addition, elucidating potential risk factors among new IDUs can help interventionists determine whether programs based on studies among older IDUs are relevant to IDUs currently starting to inject | ||||
| See individual abstracts for presenting author's disclosure statement. | ||||
| Learning Objectives: Refer to the individual abstracts for learning objectives | ||||
| Richard S. Garfein, PhD, MPH | ||||
| Alcohol use and hepatitis C prevalence among young and recent initiates to injection drug use in Los Angeles County, 1997-1999 Howard E Lee, MD, MPH, Javier L Lopez-Zetina, PhD, MA, Theresa M Woehrle, MD, MPH, Peter R Kerndt, MD, MPH | ||||
| Correlates of incarceration among young injecting drug users in New York City Barbara L. Greenberg, MSc, PhD, Vinnie Edwards, Yvonne Cuevas, Stephanie H Factor, MPH, MD, David Vlahov, PhD | ||||
| HBV Vaccination for Injecting Drug Users: Taking Services to the IDUs Don C. Des Jarlais, PhD, Jessica Clark, MPH, Judith Milliken, MA, Molly Yancovitz, Denise Paone, PhD, Theresa E. Perlis, PhD, Samuel R. Friedman, PhD | ||||
| Hepatitis C seroconversion and the multiperson use of injection paraphernalia in a cohort of young drug injectors, Chicago 1997-1999 Lorna Thorpe, MPH, Lawrence Ouellet, PhD, Susan L. Bailey, PhD, DeZheng Huo, MPH | ||||
| High Risk Behaviors Associated with Transition from Non-injection to Injection Drug Use among Young Drug Users: A Case-Control Study Crystal M. Fuller, David Vlahov, Amelia M. Arria, Danielle C. Ompad, Nina Shah, Steffanie A. Strathdee | ||||
| Young IDUs exposure to family and community violence Edward V Morse, PhD, Patricia M Morse, PhD | ||||
| Sponsor: | Alcohol, Tobacco, and Other Drugs | |||
| Cosponsors: | HIV/AIDS SPIG; Lesbian, Gay, Bisexual, and Transgender Caucus of Public Health Workers | |||